PT-141 Protocol: One Injection, Proven Results, Real Fit Rules

PT-141 works. In the U.S., it's one FDA-approved Vyleesi injection, timed before sex, with crystal-clear dosing rules. But here's what actually matters: success depends less on the protocol itself and more on whether nausea, timing, and on-demand dosing fit your real life.

The simplest PT-141 routine

In the U.S., PT-141 is bremelanotide sold as Vyleesi. The approved protocol is straightforward: 1.75 mg injected under the skin into your abdomen or thigh, used as needed, at least 45 minutes before sexual activity. The frequency rules are firm: no more than one dose in 24 hours, and no more than eight doses per month. If you haven't seen improvement after eight weeks, the label recommends stopping.

• Use it on demand, not as a daily routine.
• Give yourself at least 45 minutes before sex instead of treating it like a last-minute option.
• Keep a hard ceiling: one dose in 24 hours and no more than eight doses per month.
• Treat the first several uses as a fit check, especially if nausea tends to derail your evening.

Where and how to inject

The device is a prefilled autoinjector—no mixing required. You inject into your abdomen or the front of your thigh, always rotating sites and using a fresh injector each time. Avoid any irritated or scarred skin, and always check that the liquid is clear before you use it. If you want to understand why the approved Vyleesi form matters, this formulation explainer is the clearest reset before you go deeper.

What the research shows—and what it actually means

The phase 3 RECONNECT trials found real improvements: statistically significant increases in sexual desire and decreases in distress related to low desire, specifically in premenopausal women with acquired, generalized HSDD. A later subgroup analysis confirmed these improvements held across age, weight, BMI, and hormone profiles. The useful takeaway: this is a proven, on-demand option for one specific condition, not a universal performance enhancer.

What actually stops people from continuing

The biggest question isn't the math—it's tolerability. Nausea is common enough to make or break whether you'll use it again. You'll also need to monitor blood-pressure and heart-rate effects, which can be temporary but real. There's also a smaller but genuine risk of hyperpigmentation on the injection site. It's also not safe if you have uncontrolled high blood pressure or known heart disease. So here's the reality: the protocol is simple, but your body's response can change whether it actually works for you.

• Nausea is common and real—it's usually what decides whether the next dose feels worth it.
• Blood-pressure and heart-rate changes are part of the core picture, not a minor side note.
• This is specifically for premenopausal women with HSDD, not for men, postmenopausal women, or general performance use.
• If you're thinking about off-label versions, the approved protocol only covers part of that story.

Why PT-141 searches get so confusing

Online PT-141 conversations often blur three different things together: the FDA-approved Vyleesi autoinjector, off-label compounded versions, and nasal spray. If nasal spray is what you're actually curious about, the nasal-route guide is more useful—but it doesn't follow the same standardized protocol. And if you're still trying to figure out whether the whole effect profile sounds practical for you, this PT-141 review is the better next read.

The real takeaway

Using PT-141 is straightforward once you stick to the approved version: one on-demand Vyleesi injection, timed ahead of sex, with clear daily and monthly limits. The real decision is whether that routine fits your life well enough to stay with it. Ready to compare your options? Vyleesi vs Addyi shows how this choice stacks up against the other approved option.